NCT00790569View on ClinicalTrials.gov

Varenicline or Nicotine Patch and Nicotine Gum in Helping Smokers in a Methadone Treatment Program Stop Smoking

NACompletedINTERVENTIONAL
Enrollment

315

Participants

Timeline

Start Date

September 30, 2008

Primary Completion Date

October 31, 2012

Study Completion Date

October 31, 2012

Conditions
Bladder CancerCervical CancerEsophageal CancerGastric CancerHead and Neck CancerKidney CancerLeukemiaLiver CancerLung CancerPancreatic CancerTobacco Use Disorder
Interventions
DRUG

nicotine

Given transdermally and orally

DRUG

varenicline

Given orally

OTHER

placebo

Given orally

Trial Locations (1)

02903

Rhode Island Hospital Comprehensive Cancer Center, Providence

Sponsors

Lead Sponsor

Butler Hospital
All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Butler Hospital

OTHER

NCT00790569 - Varenicline or Nicotine Patch and Nicotine Gum in Helping Smokers in a Methadone Treatment Program Stop Smoking | Biotech Hunter | Biotech Hunter